TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy is a research paper published in Cell (2020). On theSindex it has a DataRank of 0.964. It has been cited 617 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.964
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIA NIH HHS
Grant: RF1 AG051485
NIAID NIH HHS
Grant: R01 AI114551
NCI NIH HHS
Grant: R01 CA190700
NCI NIH HHS
Grant: R01 CA235096
NCI NIH HHS
Grant: P30 CA091842
NIA NIH HHS
Grant: RF1 AG059082
NIAMS NIH HHS
Grant: R01 AR066551
NIDDK NIH HHS
Grant: R01 DK058177
NIA NIH HHS
Grant: R21 AG059176
National Institutes of Health
FWCI
22.13
Citation Percentile
1.0%
Influential Citations
26
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
Additional file 1 of Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
Additional file 2 of Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions
Additional file 2 of Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions
Additional file 1 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
Additional file 1 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
Additional file 2 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
Additional file 2 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
Additional file 1 of Galectin-3 induces pathogenic immunosuppressive macrophages through interaction with TREM2 in lung cancer
Additional file 1 of Galectin-3 induces pathogenic immunosuppressive macrophages through interaction with TREM2 in lung cancer
Additional file 1 of Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways
Additional file 1 of Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways
Additional file 3 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
Additional file 3 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
Additional file 4 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
Additional file 4 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
Additional file 1 of Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions
Additional file 1 of Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions